EyeYon Medical Ltd.

EyeYon Medical Ltd. specialises in ophthalmic devices. Their portfolio includes the Hyper-CL, a contact lens, and the EndoArt®, a synthetic implant designed specifically for corneal edema. These devices are intended to improve corneal transparency and provide alternatives to traditional corneal transplant surgeries, addressing conditions that impair vision due to corneal swelling or opacity.

EyeYon Medical Ltd. is headquartered in Israel. The company’s location in Israel aligns with its focus on developing innovative ophthalmic solutions, leveraging local expertise in medical technology and research.

EyeYon Medical Ltd.’s devices are registered in the eudamed database, which is the European Union’s centralised registry for medical devices. This registration ensures transparency and compliance with EU regulatory requirements for devices classified under Class IIa and Class IIb.

EyeYon Medical Ltd.’s devices are classified as Class IIa and Class IIb under EU medical device regulations. This classification is based on their intended use and associated risks—Class IIa devices pose moderate risks requiring special measures, while Class IIb devices carry higher risks, necessitating stricter controls to ensure safety and performance.